health
STAT+: What does DeGette’s loss mean for pharma?
Why this matters: health reporting relevant to everyday decisions and well-being.
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine.&#x A0;Sign up here&#x A0;to receive it in your inbox on Tuesdays and Thursdays. RFK Jr. said on Fox News that he’ll leave raccoons alone “for the moment.” Send news tips and ideas for roadkill excursions to John.Wilkerson@statnews.com or John_Wilkerson.07 on Signal. De Gette’s loss is a mixed bag for drug industry. The drug industry will lose a key Democratic lawmaker who was knowledgeable about the industry, if not always a friend.Continue to STAT+ to read the full story…
Article preview — originally published by STAT News. Full story at the source.
Read full story on STAT News →
More top stories
Also covered by
Aggregated and edited by the Scoop newsroom. We surface news from STAT News alongside other reporting so you can compare coverage in one place.
Editorial policy · Corrections · About Scoop